Lori J. Braender - 07 May 2026 Form 4 Insider Report for Aquestive Therapeutics, Inc. (AQST)

Reporting relationship: Corporate Secretary
Issuer ticker: AQST
Reported as of: 07 May 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 11 May 2026, 16:35:43 UTC
Prior SEC filing: 07 May 2026
Source filing: View source filing
Reporting owner signature: /s/ Thomas Zalewski, as Attorney-In-Fact

Key filing fact

Lori J. Braender filed Form 4 for Aquestive Therapeutics, Inc. (AQST) on 11 May 2026.

Key facts

This page summarizes Lori J. Braender's Form 4 filing for Aquestive Therapeutics, Inc. (AQST).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 11 May 2026, 16:35.

Change

Previous filing in this sequence was filed on 07 May 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001752955 Primary reporting owner

BRAENDER LORI J

Relationship: Corporate Secretary
Address: C/O AQUESTIVE THERAPEUTICS, INC., 30 TECHNOLOGY DRIVE, WARREN
Signature: /s/ Thomas Zalewski, as Attorney-In-Fact
Signature date: 11 May 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

AQST transaction

Common Stock

Tax liability

Transaction value
Shares: -135,690
Change %: -37%
Price: $4.23^*
Shares after: 231,042
Date: 07 May 2026
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

Lori J. Braender is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 1 footnote

Footnote F1

Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person.

SEC remarks

Former Chief Legal Officer and Chief Compliance Officer